🌅 Today's Morning Call
|
S&P Futures
6,804.75
▼ -5.00 (-0.07%)
|
Nasdaq Futures
25,028.00
▲ +11.50 (+0.05%)
|
Dow Futures
47,961.00
▼ -115.00 (-0.24%)
|
|
10Y Treasury
4.29%
▼ -0.05%
|
US Dollar
98.91
▼ -0.15 (-0.15%)
|
Bitcoin
$71,212
▲ +$96 (+0.14%)
|
Data as of 8:07 AM ET
Good morning! Thursday morning is bringing us a mixed bag of futures action with tech holding up while broader markets take a breather. The relief rally that's been lifting stocks is showing signs of fatigue, but there's plenty of corporate news to digest this morning. From pharma breakthroughs to chip milestones and EV strategy shifts, here's what's moving markets before the bell.
👀 What to Watch Today
The main event today is watching how investors digest this wave of major corporate announcements, particularly in healthcare and technology. Eli Lilly (LLY) is officially launching Foundayo in the U.S., marking a significant milestone in the obesity treatment market that could shake up the competitive landscape with Novo Nordisk. This is the kind of product launch that can move not just the stock, but the entire healthcare sector.Amazon (AMZN) is revealing something that's been flying under the radar: its chip business is now a $20 billion annual revenue operation. CEO Andy Jassy is putting real numbers behind the Graviton and Trainium processors, showing that Amazon's cloud dominance extends well beyond renting server space. This validates the company's massive capital expenditures and positions it squarely against Nvidia (NVDA) and other semiconductor players.
BlackBerry (BB) is declaring victory in its turnaround effort, projecting first-quarter revenue will beat expectations thanks to cybersecurity and embedded software demand. Meanwhile, Tesla (TSLA) is reportedly developing a smaller, more affordable electric SUV according to Reuters sources, potentially addressing the biggest criticism of its lineup: price accessibility. These are the stories that could drive sector rotation today.
🌏 Overnight Recap
Global markets are showing that cautious tone the Morning Brief headline warned about, with the relief rally taking a pause across major indices. Asian markets closed mixed as traders digested the latest economic data from China and awaited more clarity on U.S.-China trade dynamics. Japanese equities dipped slightly while Hong Kong's Hang Seng managed modest gains on tech strength.European markets are treading water this morning, with banking stocks drawing attention after UniCredit (UNCFF) warned that its potential Commerzbank (CRZBF) merger could trigger staff departures and client losses. The Italian bank's candid assessment of merger risks is putting a damper on European financials, though the broader indices are holding relatively steady.
Treasury yields are ticking lower across the curve, with the 10-year pulling back to 4.29% and giving growth stocks some breathing room. The dollar is also softening, down 0.15% on the DXY, which typically provides a tailwind for multinational corporations and commodities. Bitcoin is edging higher above $71,000, suggesting risk appetite hasn't completely evaporated overnight.
Sponsored Content
Get This Stock Now
This company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardware is so essential that the data center industry uses enough of it to stretch around the world 8 times – in a single building! So, if you own Nvidia stock now, you might be well-served to sell those shares and check out this under-the-radar play instead. Or if you missed the boat on Nvidia, this is a rare second chance to target tremendous profit potential as AI data centers spring up in every corner of the world.
📊 Pre-Market Movers
Eli Lilly (LLY) is the headliner this morning after officially launching Foundayo, its FDA-approved weight-loss pill, in the U.S. market. This puts Lilly in direct competition with the existing GLP-1 heavyweights and could capture significant market share given the pill format versus injections. Expect healthcare analysts to be all over this one with revised price targets and market sizing estimates.Amazon (AMZN) should see action after CEO Andy Jassy disclosed that the company's chip business is generating over $20 billion in annual revenue. That's not a typo: $20 billion from Graviton and Trainium processors. This revelation shows Amazon isn't just a cloud infrastructure player but a legitimate semiconductor company that's vertically integrated and competing directly with the chip giants.
BlackBerry (BB) is moving in pre-market after projecting first-quarter revenue above expectations, driven by strong cybersecurity and embedded software demand. The company is officially calling its turnaround complete, which is bold language that suggests management confidence. Tesla (TSLA) could see volatility on reports it's developing a smaller, more affordable electric SUV, addressing one of the key barriers to mass adoption: price point.
🔍 Today's Watchlist
- Eli Lilly (LLY) Foundayo launch and competitive positioning against obesity drug rivals
- Amazon (AMZN) $20B chip revenue reveal and implications for AWS growth trajectory
- Tesla (TSLA) affordable EV development and potential market share expansion
- Treasury yields declining across the curve, with 10-year at 4.29%
- BlackBerry (BB) turnaround validation and cybersecurity demand strength
Sponsored Content
A Setup That’s Still Flying Under the Radar
There's a quiet stage before a stock ever becomes a talking point. No buzz, no urgency — just a few data points starting to line up. We're tracking a small-cap with limited availability, improving business conditions, and renewed sector activity. Still under the radar. We put together a short free report on what we're seeing.
🎯 The Morning Playbook
Today's playbook is about separating signal from noise in a market that's catching its breath after a relief rally. The futures are mixed, the rally is pausing, but the underlying corporate stories are strong. Focus on companies making tangible business announcements rather than chasing momentum.The Eli Lilly launch, Amazon's chip disclosure, and BlackBerry's turnaround claim are all data points that change investment theses. These aren't just headlines; they're revenue events and competitive positioning shifts. Tesla's affordable EV development, if confirmed, addresses the elephant in the room for mass market adoption.
With yields pulling back and the dollar softening, the macro backdrop isn't fighting you today. Watch how these individual stock stories play out, because in a mixed market, stock selection matters more than broad index direction. Sometimes the best trading days are the ones where the market gives you time to think.